معرفی
Jing Sun, MD, PhD, MPH is an Associate Research Professor in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. Her primary departmental affiliation is with the Infectious Disease Epidemiology division, and she holds significant center affiliations including the Johns Hopkins Center for AIDS Research (CFAR) and the AIDS Linked To the Intravenous Experience (ALIVE) cohort study. She is also involved with the MACS/WIHS Combined Cohort Study and contributes to the National COVID Cohort Collaborative (N3C).
Dr. Sun earned her MD from Guangdong Medical University (2008), MPH from the University of Wisconsin (2011), and PhD from Drexel University (2015). Her educational background spans clinical medicine, public health, and epidemiological research methods.
As a molecular epidemiologist specializing in HIV and aging, Dr. Sun's research focuses on molecular factors impacting long-term health outcomes of people living with chronic infections, particularly HIV and viral hepatitis. Her work centers on investigating age-related biomarkers, especially mitochondrial function, on multi-organ aging among people living with HIV. She also examines the impact of viral hepatitis and HIV coinfections on liver disease progression. During the COVID-19 pandemic, her research with the N3C addressed risk of severe outcomes and vaccine effectiveness among immunocompromised populations, with findings cited by the CDC in vaccine prioritization decisions.
Her extensive publication record (55+ publications) demonstrates consistent research productivity, with recent work spanning HIV and aging, injection drug use epidemiology, social determinants of health, and the intersection of HIV with emerging infectious diseases like COVID-19. Her research employs diverse methodologies including molecular epidemiology, cohort studies, computational phenotyping, and machine learning approaches to identify risk factors and health disparities.
Dr. Sun has received numerous prestigious awards including the CFAR Scholar Faculty Development Award (2019), Cooper Scholar designation (2018), New Investigator Scholarship at CROI (2018), and multiple travel and mentoring awards supporting her work in HIV and aging research.
Her collaborative research involves significant work with the ALIVE cohort (a longitudinal study of people who inject drugs in Baltimore), the MACS/WIHS Combined Cohort Study, and the National COVID Cohort Collaborative. She frequently collaborates with interdisciplinary teams spanning epidemiology, infectious diseases, biostatistics, and computational sciences to address complex questions in HIV epidemiology and aging.
